secwatch.observer — SEC 8-K summary
======================================

Issuer:     NEPHROS INC (NEPH)
CIK:        0001196298
Form:       8-K
Filed at:   2022-10-11T23:59:59+00:00
Accession:  0001493152-22-028035
Event type: m_and_a
Sentiment:  neutral
Materiality: 0.75
Item codes: 1.01, 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Nephros sells Pathogen Detection Systems business, reports prelim Q3 revenue ~$2.5M
--------------------------------------------------------------------------------

- Entered definitive agreement to sell Pathogen Detection Systems (PDS) business to BWSI; expected close mid-November 2022.
- Sale includes seven-year earn-out based on a portion of gross profits from PDS products.
- Preliminary Q3 2022 revenue expected ~$2.5M; Active Customer Sites up 18% YoY to 1,391.
- Cash position ~$3.9M at quarter end; sale expected to reduce expenses by ~$350k per quarter.
- Company aims for positive net cash flow by mid-2023.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1196298/000149315222028035/0001493152-22-028035-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1196298/000149315222028035/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-22-028035

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer